Quick Answer
LIXTE BIOTECHNOLOGY HOLDINGS, INC. reported Total Assets of $12.73 million for the year ending 2025.
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. showed an increase of +1,011.6% in Total Assets from 2024 to 2025.
- This data is from LIXTE BIOTECHNOLOGY HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $1.42 million | Q3 2011: $1.00 million | Q1 2012: $201.6 thousand | Q2 2012: $2.25 million | Q3 2012: $1.96 million | Q1 2013: $1.48 million | Q2 2013: $1.14 million | Q3 2013: $873.8 thousand | Q1 2014: $187.9 thousand | Q2 2014: $1.30 million | Q3 2014: $996.2 thousand | Q1 2015: $1.68 million | Q2 2015: $1.52 million | Q3 2015: $1.03 million | Q1 2016: $1.22 million | Q2 2016: $1.38 million | Q3 2016: $933.6 thousand | Q1 2017: $920.6 thousand | Q2 2017: $2.06 million | Q3 2017: $1.65 million | Q1 2018: $854.6 thousand | Q2 2018: $582.8 thousand | Q3 2018: $444.9 thousand | Q1 2019: $3.95 million | Q2 2019: $3.62 million | Q3 2019: $3.07 million | Q1 2020: $2.28 million | Q2 2020: $1.89 million | Q3 2020: $1.36 million | Q1 2021: $7.89 million | Q2 2021: $7.24 million | Q3 2021: $6.33 million | Q1 2022: $4.12 million | Q2 2022: $8.02 million | Q3 2022: $6.82 million | Q1 2023: $4.33 million | Q2 2023: $3.10 million | Q3 2023: $5.23 million | Q1 2024: $3.59 million | Q2 2024: $2.67 million | Q3 2024: $1.70 million | Q1 2025: $1.51 million | Q2 2025: $1.19 million | Q3 2025: $5.43 million.
- Over the full 16 years of available data (2010 to 2025), LIXTE BIOTECHNOLOGY HOLDINGS, INC.'s Total Assets has grown by 559.3%.
- Historical annual values: Fiscal year 2025: $12.73 million | Fiscal year 2024: $1.15 million | Fiscal year 2023: $4.31 million | Fiscal year 2022: $5.56 million | Fiscal year 2021: $5.09 million | Fiscal year 2020: $5.23 million | Fiscal year 2019: $2.67 million | Fiscal year 2018: $4.34 million | Fiscal year 2017: $1.37 million | Fiscal year 2016: $433.4 thousand | Fiscal year 2015: $598.0 thousand | Fiscal year 2014: $539.3 thousand | Fiscal year 2013: $558.0 thousand | Fiscal year 2012: $1.75 million | Fiscal year 2011: $429.8 thousand | Fiscal year 2010: $1.93 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: